Collegeville, PA, United States of America

Meagan B Rouse

USPTO Granted Patents = 18 (Patent Applications = 9)

CIPO Patents = 1

EPO Patents = 7 (Patent Applications = 11)

Average Co-Inventor Count = 3.8

ph-index = 6

Forward Citations = 91(Granted Patents)

Company Filing History:

Glaxosmithkline Intellectual Property (no.2) Limited

patents

Years Active: 2009-2016

Loading Chart...

18 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 9402836 - Indoles (2016-08-02),

2. 9346840 - Cyclopropylamines as LSD1 inhibitors (2016-05-24),

3. 9073924 - Azaindazoles (2015-07-07),

4. 9018382 - Indazoles (2015-04-28),

5. 8975291 - Indoles (2015-03-10),

6. 8946278 - Inhibitors of AkT activity (2015-02-03),

7. 8846935 - Indazoles (2014-09-30),

8. 8637509 - Azaindazoles (2014-01-28),

9. 8592475 - Inhibitors of Akt activity (2013-11-26),

10. 8420690 - Inhibitors of Akt activity (2013-04-16),

11. 8410158 - Inhibitors of Akt activity (2013-04-02),

12. 8338434 - Inhibitors of Akt activity (2012-12-25),

13. 8273782 - Inhibitors of Akt activity (2012-09-25),

14. 7759340 - Antibacterial agents (2010-07-20),

15. 7709472 - Antibacterial agents (2010-05-04),

Title: Meagan B Rouse: A Trailblazer in Cancer Research Innovations

Introduction

Meagan B Rouse, based in Collegeville, Pennsylvania, is an accomplished inventor with an impressive portfolio of 18 patents. Her groundbreaking work primarily focuses on innovations that contribute to cancer treatment, showcasing her commitment to advancing medical science.

Latest Patents

Among her notable inventions are patents involving indoles, disclosed under the formula (I), which are identified as useful compounds for treating cancer. Additionally, she has developed cyclopropylamines as inhibitors of Lysine-specific demethylase 1 (LSD1), further enhancing the potential for cancer treatment. These innovations reflect her dedication to improving therapeutic approaches in oncology.

Career Highlights

Throughout her career, Meagan B Rouse has made significant contributions to the field of pharmaceutical sciences, working at reputable organizations such as GlaxoSmithKline LLC and Glaxo Group Limited. Her expertise and innovative mindset have established her as a notable inventor in the industry.

Collaborations

Meagan's journey has also been marked by collaboration with prominent professionals in her field. She has worked alongside William Henry Miller and Mark Andrew Seefeld, exchanging knowledge and ideas that have propelled advancements in cancer research.

Conclusion

Meagan B Rouse represents the spirit of innovation in the fight against cancer, with her extensive list of patents underscoring her impact in the medical research community. Through her continued efforts and collaborations, she is paving the way for new therapeutic strategies that hold promise for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.